1.0 CEUs
PrEP and PEP: Pharmacist-Led Care Models
Module DescriptionPharmacist-led care models have become increasingly popular in recent years, especially in the management of chronic diseases. In the case of HIV prevention, pharmacists can play a critical role in improving access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for individuals at risk of acquiring HIV.
This webinar will describe pharmacist-led care models on HIV PrEP and PEP, including the impact on HIV prevention and care, various state laws, practice environments, and professional and financial sustainability.
Credit Dates06/15/2023 – 06/14/2024
Jointly provided by Postgraduate Institute for Medicine and the American Academy of HIV Medicine.
This educational activity is supported by an independent medical education grant from ViiV Healthcare.
This webinar will describe pharmacist-led care models on HIV PrEP and PEP, including the impact on HIV prevention and care, various state laws, practice environments, and professional and financial sustainability.
Credit Dates06/15/2023 – 06/14/2024
Jointly provided by Postgraduate Institute for Medicine and the American Academy of HIV Medicine.
This educational activity is supported by an independent medical education grant from ViiV Healthcare.
Learning Objectives
- Describe how pharmacist-led PEP and PrEP initiatives function in various practice settings
- Highlight differences in state laws, and how that affects pharmacist-led PEP and PrEP initiatives
- Provide basic care provision components that should be included in pharmacist-led PEP and PrEP initiatives, regardless of practice setting state law
- Describe scenarios of financial sustainability in pharmacist-led PEP and PrEP initiatives
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers, are also encouraged to attend.
PresentersModerator
Kevin Aloysius, PharmD, AAHIVP, RPh
Director‑ Pharmacy Operations, Clinic
Montrose Clinic
Houston, Texas
Dan Scales, PharmD, AAHIVP
Director of Pharmacy Collaborative Care
Vivent Health
Denver, CO
Jim Scott, PharmD, AAHIVE
Dean, College of Pharmacy
Touro University California
Vallejo, CA
Samantha Strong, PharmD, BCACP, CDCES, AAHIVP
Clinical Director of Pharmacy
Nevada Health Centers
Las Vegas, NV
Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity.
During the period June 15, 2023, through June 14, 2024, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. Click "Find Post-test/Evaluation by Course" on the navigation menu and search by course ID 17603. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within four weeks.
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com or visit www.pimed.com.In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the American Academy of HIV Medicine. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education Credit
The Postgraduate Institute for Medicine designates this internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
The Postgraduate for Medicine designates this continuing education activity for 1.0 contact hours (0.1 CEUs) of Accreditation Council for Pharmacy Education Universal Activity #JA4008162-9999-23-237-H02-P
Type of Credit: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Disclosure of Conflict of Interest Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated:
The speakers have nothing to disclose.
Planners and Managers
The PIM planners and managers have nothing to disclose.
The AAHIVM planners and managers have nothing to disclose.
Media: Internet
Computer System Requirements: This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.
Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
